Tablets & Capsules

TC0721

Issue link: https://www.e-digitaleditions.com/i/1393031

Contents of this Issue

Navigation

Page 39 of 51

32F July/August 2021 Tablets & Capsules 15. Clapp, Megan et al, Gut microbiota's effect on men- tal health: The gut-brain axis, Clinics and Practice vol. 7,4 987, (2017), https://www.ncbi.nlm.nih.gov/pmc/articles/ PMC5641835/. 16. FMCG Gurus: Top Ten Trends for 2020, January 2020 (Results based on FMCG Gurus Immunity survey in Q3 2019). 17. Zheng, D., Liwinski, T. & Elinav, E., Interaction between microbiota and immunity in health and disease, Cell Res 30, 492–506 (2020), https://doi.org/10.1038/ s41422-020-0332-7, introduction. 18. FMCG Gurus: What's next for Immune Health in 2021. 19. Plaza-Diaz, J., et al. (2014) PLoS One. 9(5): p. e98401 (study showed L rhamnosus to lower only TNF-alpha). 20. Munoz-Quezada, S., et al. (2013) Br J Nutr. 109 (S2): p. S63-S69. 21. Plaza-Diaz, J., et al. (2013) PLoS One. 8(10): p. e78111. 22. Commission Regulation (EU) No 432/2012of 16 May 2012. Official Journal of the European Union L 136/1 (May 25, 2012) [https://eur-lex.europa.eu/legal-content/ EN/TXT/PDF/?uri=CELEX:32012R0432&from=EN]. Marta Tortajada Serra is vice president of science and tech- nology health and wellness at ADM (www.adm.com, 312 634 8100). 6. FMCG Gurus: Probiotics in 2021, February 2021. 7. The Hartman Consumer Research October 2020, slide 82. 8. Vinod K. Gupta, Sandip Paul and Chitra Dutta, Geography, Ethnicity or Subsistence-Specific Variations in Human Microbiome Composition and Diversity, Fron- tiers in Microbiology (2017), https://www.ncbi.nlm.nih.gov/ pmc/articles/PMC5481955/. 9. Pedret. Pedret A, Valls RM, Calderón-Pérez L, et al, Effects of daily consumption of the probiotic Bifidobacte- rium animalis subsp. lactis CECT 8145 on anthropometric adiposity biomarkers in abdominally obese subjects: a ran- domized controlled trial, Int J Obes (Lond) 43(9):1863‐1868, (2019) doi:10.1038/s41366-018-0220-0. 10. Amat-Bou. Amat-Bou, M.; Garcia-Ribera, S.; Climent, E.; Piquer-Garcia, I.; Corripio, R.; Sanchez- Infantes, D.; Villalta, L.; Elias, M.; Jiménez-Chillarón, J.C.; Chenoll, E.; Ramón, D.; Ibañez, L.; Ramon-Krauel, M.; Lerin, C, Effects of Bifidobacterium animalis Subsp. lactis (BPL1) Supplementation in Children and Adoles- cents with Prader–Willi Syndrome: A Randomized Cross- over Trial, Nutrients, 12, 3123, (2020). 11. Balaguer, F., et al, Microbial Biotechnology 0(0): 1-12 (2021). 12. ADM OutsideVoice. 13. The Hartman Consumer Research, October 2020. 14. The Hartman Consumer Research, October 2020. sotax.com/xtend Solutions for Pharmaceutical Testing Ready for tomorrow. Today. Respond flexibly to changing workloads and simplify method transfer with the Xtend ™ Dissolution Line. Standardized modules such as dissolution bath, pump, and sample manager can be flexibly combined or extended anytime – from manual to semi- and fully automated systems. Ready for tomorrow. Today. Respond flexibly to changing workloads and simplify method transfer Modular. Scalable. Future-proof. Xtend ™

Articles in this issue

Links on this page

Archives of this issue

view archives of Tablets & Capsules - TC0721